AKBLF (AKBLF) Stock Price & Analysis
AKBLF (AKBLF) fell 19.39% to USD 31.35 as of June 10, 2026 at 01:11 UTC, according to Nexqual real-time market data.
AKBLF last closed at USD 38.89; the session ranged USD 31.35–31.35 on volume of 105 shares. Market capitalization is $6.95B, with a 52-week range of USD 26.99–38.89 (PNK). Source: Nexqual, June 10, 2026 at 01:11 UTC.
Key Statistics (as of June 10, 2026 at 01:11 UTC)
| Price | USD 31.35 |
|---|---|
| Change | ▼ 19.39% (down) |
| Previous Close | USD 38.89 |
| Open | USD 31.35 |
| Day Range | USD 31.35 – 31.35 |
| 52-Week Range | USD 26.99 – 38.89 |
| Volume | 105 shares |
| Market Cap | $6.95B |
| Exchange | PNK |
Technical Analysis (AKBLF)
Nexqual's technical model rates AKBLF "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 01:11 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 35.38) |
| MACD | 0.97 (positive) |
Analyst Ratings (AKBLF)
Wall Street analysts rate AKBLF "None", per Nexqual as of June 10, 2026 at 01:11 UTC.
| Consensus Rating | None |
|---|
Earnings (AKBLF)
| Next Earnings Date | 2026-05-04 |
|---|---|
| Revenue Estimate | $1.73B |
Source: Nexqual, June 10, 2026 at 01:11 UTC.
Financials & Fundamentals (AKBLF)
| Total Revenue | $6.56B |
|---|---|
| Revenue Growth (YoY) | +16.40% |
| Gross Margin | +67.92% |
| Operating Margin | +32.19% |
| Profit Margin | +19.51% |
| ROE | +20.91% |
| Debt / Equity | 6.24 |
| Current Ratio | 3.25 |
| Total Cash | $1.54B |
| Total Debt | $410.00M |
| Free Cash Flow | $872.75M |
Source: Nexqual, June 10, 2026 at 01:11 UTC.
Financial Health Score (AKBLF)
Nexqual rates AKBLF's overall financial health "Strong" across five dimensions, as of June 10, 2026 at 01:11 UTC.
| Growth | Solid — Revenue +14% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 68%, operating 32% |
| Balance Sheet | Strong — $1.54B cash vs $410M debt, net cash position |
| Cash Flow | Solid — FCF $873M, 14% margin |
| Efficiency | Strong — ROE 21%, ROA 12.6% |
Ownership (AKBLF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +64.27% |
| Shares Outstanding | 201.33M |
| Float | 131.81M |
Source: Nexqual, June 10, 2026 at 01:11 UTC.
Leadership (AKBLF)
AKBLF is led by Peter Halling (age 48), President, CEO & Member of Management Board, per Nexqual as of June 10, 2026 at 01:11 UTC.
| President, CEO & Member of Management Board | Peter Halling (age 48) |
|---|---|
| Executive VP, CFO & Member of Management Board | Claus Steensen Solje (age 53) |
| Senior Project Director, Global Clinical Development & Employee-elected Director | Katja Barnkob Thalund (age 56) |
| Senior Manager of QA Release & Employee Representative Director | Nanna Rassov Carlson (age 49) |
| Senior Maintenance Supporter of Process & Production Support & Employee Representative Director | Johan Smedsrud (age 53) |
Major Backers & Investors (AKBLF)
Notable institutional backers of AKBLF include DFA INVESTMENT TRUST CO-The Continental Small Company Series, Artisan Partners Funds Inc.-Artisan International Small-Mid Fund, AIM Fd.s Group -Invesco Intl Small Company Fd., according to Nexqual as of June 10, 2026 at 01:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT TRUST CO-The Continental Small Company Series | 0.66% |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 0.27% |
| AIM Fd.s Group -Invesco Intl Small Company Fd. | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.97% |
| BlackRock | 0.75% |
Source: Nexqual, June 10, 2026 at 01:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNMSF | Genmab A/S | USD 249 | ▼ 0.18% |
| BVNKF | Bavarian Nordic A/S | USD 29.41 | ▲ 5.72% |
| AKESF | AKESO INC. | USD 12 | ▼ 0.83% |
| ZLDPF | Zealand Pharma A/S | USD 42.03 | ▼ 15.52% |
| UCBJY | UCB S.A. | USD 151.74 | ▲ 1.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:11 UTC. This page is informational and not investment advice.